SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
iAnthus disclosed Q2 2026 financial results (quarter ended June 30, 2026) via press release on August 12, 2026, reporting revenue of $35.3M, gross profit of $16.1M, net loss of $14.4M, and Adjusted EBITDA of $4.4M with sequential and year-over-year comparisons.
View raw filing on EDGAR →Pershing Square Inc. disclosed its second quarter 2026 financial results on August 12, 2026, via press release and earnings presentation. The disclosure includes detailed GAAP income statements, balance sheet highlights, assets under management data, and fee-related earnings metrics for the period ended June 30, 2026.
View raw filing on EDGAR →WhiteHawk Minerals disclosed financial results for the second quarter ended June 30, 2026, via press release issued August 12, 2026, reporting revenue of $29.1 million, net loss of $39.2 million, and production of 70.0 MMcfe/d.
View raw filing on EDGAR →BioStem issued a press release on August 12, 2026 announcing financial results for Q2 2026 (three and six months ended June 30, 2026), disclosing net revenue of $7.9 million, gross profit of $4.8 million, and a GAAP net loss of $9.0 million per share. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes detailed financial statements, guidance updates, and operational metrics material to investor assessment.
View raw filing on EDGAR →This is a formal earnings release dated August 12, 2026, disclosing Valens Semiconductor's Q2 2026 financial results (revenue of $18.1 million, gross margin of 61.5% GAAP, net loss of $8.1 million) and raising full-year 2026 revenue guidance to $78.0–$81.0 million. The document includes detailed financial statements, segment performance, and forward-looking guidance, all hallmarks of a quarterly earnings announcement. Material to investors as it affects assessment of the company's financial performance and outlook.
View raw filing on EDGAR →T1 Energy issued a press release on August 12, 2026 announcing Q2 2026 financial results, disclosing net sales of $250.1 million, net loss from continuing operations of $(36.9) million, and Adjusted EBITDA of $10.7 million, accompanied by an earnings call presentation.
View raw filing on EDGAR →This is a press release dated August 12, 2026, announcing RADCOM's second quarter 2026 financial results. The exhibit discloses quarterly revenues ($11.8 million), operating results (GAAP operating loss of $3.8 million), net loss ($3.1 million), and six-month results, along with consolidated financial statements. The disclosure is material as it reports a significant 33.4% year-over-year revenue decline and shift from profitability to losses, which would affect a reasonable investor's assessment of the company's financial performance and outlook.
View raw filing on EDGAR →This is a press release disclosing Q2 2026 financial results (net loss of $7.8M for three months, $15.6M for six months) alongside material corporate developments including FDA NDA acceptance with Priority Review, a $320M partnership with Azurity Pharmaceuticals, and a PDUFA goal date of November 28, 2026. While the release bundles multiple material events, the primary disclosure vehicle is the earnings announcement with accompanying financial statements (balance sheet and income statement), making this an earnings_release. The material partnership and regulatory milestones are disclosed as corporate highlights within the earnings context.
View raw filing on EDGAR →Kornit Digital reported Q2 2026 financial results on August 12, 2026, with revenues of $55.3M (+11% YoY), Adjusted EBITDA of $0.3M, and ARR of $33.8M (+79% YoY), along with forward guidance for Q3 and H2 2026. The disclosure includes consolidated financial statements, GAAP to non-GAAP reconciliations, and supporting presentation slides for the earnings conference call.
View raw filing on EDGAR →This is a standard earnings release disclosing Q2 2026 financial results for Unicycive Therapeutics. The filing explicitly states under Item 2.02 that the company "issued a press release announcing its financial results for the second quarter ended June 30, 2026" with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial statements (balance sheet, income statement) and per-share metrics (net loss of $(0.06) per share), along with a business update regarding the company's lead drug candidate OLC. This is a material disclosure affecting investor assessment of the registrant's financial condition and operational progress.
View raw filing on EDGAR →This is a press release announcing IceCure's financial results for the first half of 2026, disclosing revenue of $1.8 million (45% year-over-year growth), gross profit of $548,000, and a net loss of $8.775 million. The exhibit includes condensed consolidated financial statements (balance sheet, income statement, and cash flows) for the six-month period ended June 30, 2026, along with operational highlights such as 70% growth in active installed base and $8.5 million in capital raised. This is a discrete earnings announcement, not a periodic financial report filing itself.
View raw filing on EDGAR →LiveOne issued a press release on August 12, 2026 announcing Q1 Fiscal 2027 financial results for the quarter ended June 30, 2026, including revenue of $19.4M and adjusted EBITDA of $4.3M (a $6.1M year-over-year improvement), along with consolidated financial statements and non-GAAP reconciliations.
View raw filing on EDGAR →PodcastOne disclosed its Q1 Fiscal 2027 financial results on August 12, 2026, via press release, reporting revenue of $16.1M (up 8% YoY), Adjusted EBITDA of $1.6M (up 172% YoY), and a net loss of $1.6M, along with detailed consolidated financial statements.
View raw filing on EDGAR →The filing discloses Spectral AI's financial results for Q2 2026 (quarter ended June 30, 2026), including revenue of $3.5 million, net loss of $(4.2) million, and cash position of $14.0 million. The press release (Exhibit 99.1) provides a comprehensive earnings announcement with detailed financial metrics, business highlights including FDA clearance for the DeepView System, and forward guidance of $18.5 million revenue for 2026. This is a standard quarterly earnings release disclosed via Item 2.02 and Item 7.01.
View raw filing on EDGAR →Longeveron issued a press release on August 12, 2026 announcing financial and operating results for the three and six months ended June 30, 2026, including detailed quarterly financial metrics (revenues, expenses, net loss, cash position) and business updates. The disclosure is a standard quarterly earnings announcement with financial results and operational highlights, which is the core purpose of Item 2.02 disclosures.
View raw filing on EDGAR →Toppoint Holdings disclosed second quarter 2026 financial results via press release, reporting revenue of $4.6 million (up 17% year-over-year), gross margin improvement to 8%, and net loss narrowing 80% to $306,711.
View raw filing on EDGAR →This is a straightforward earnings release disclosing quarterly financial results for Q2 2026 (quarter ended June 30, 2026). The filing explicitly states "On August 12, 2026, Gaxos.ai Inc. announced financial results for the quarter ended June 30, 2026" under Item 2.02, with the press release furnished as Exhibit 99.1. The press release reports record consolidated revenue of $2.46 million (up 35.8% sequentially and 1,337% year-over-year), GAAP net income of $241,056, and other key financial metrics. This is material to investors as it discloses the company's operating and financial performance.
View raw filing on EDGAR →The filing discloses Q2 2026 financial results for the period ended June 30, 2026, including revenue ($124,914), operating expenses, net loss ($2.9 million), and cash position ($27.7 million). The press release, furnished as Exhibit 99.1, is the primary disclosure vehicle for these quarterly financial results, which is the hallmark of an earnings release under Item 2.02. While the filing also mentions going-concern alleviation and a private placement, the core Item 2.02 disclosure centers on the quarterly financial results announcement.
View raw filing on EDGAR →Turn Therapeutics issued a press release on August 12, 2026 announcing financial and operating results for the quarter ended June 30, 2026, including consolidated statements of operations and selected balance sheet data. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The filing includes quarterly financial metrics (operating expenses, net loss, loss per share, cash position) and is material to investors assessing the company's financial condition and operational progress.
View raw filing on EDGAR →SUNation Energy issued a press release on August 12, 2026 announcing financial results for Q2 2026 (quarter ended June 30, 2026), disclosing consolidated revenue of $8.2 million, gross profit of $2.1 million, operating loss of $3.18 million, and net loss of $3.34 million. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the registrant's financial performance and operational trends.
View raw filing on EDGAR →This is a press release announcing Cyngn's financial results for Q2 2026 (six months ended June 30, 2026), filed under Item 2.02 Results of Operations and Financial Condition. The disclosure includes detailed consolidated statements of operations, balance sheets, and cash flows, along with narrative discussion of revenue ($249k YTD), net loss ($12.8M YTD), and cash position ($39.7M). This is a standard earnings release that would materially affect a reasonable investor's assessment of the company's financial condition and operating performance.
View raw filing on EDGAR →New Concept Energy reported Q2 2026 financial results on August 10, 2026, disclosing revenue of $41,000 and a net loss of $66,000 for the quarter, along with condensed consolidated balance sheets and statements of operations.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Ashford Hospitality Trust, Inc. (the 'Company') issued a press release announcing its financial results for the second quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The filing includes consolidated balance sheets, statements of operations, and detailed financial highlights including net income, EBITDA, and per-share metrics, which are hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →This is a news release dated August 12, 2026, announcing "2026 Second Quarter Financial Results and Operating Highlights" for First Mining Gold Corp. The release explicitly states that "financial statements and management's discussion and analysis ('MD&A') are available" and reports Q2 2026 results for the quarter ended June 30, 2026. While the release emphasizes operational highlights (environmental approvals, Indigenous agreements, exploration results, and asset transactions), it is fundamentally structured as a quarterly earnings announcement disclosing financial results alongside operational context, making it an earnings_release rather than a purely operational disclosure.
View raw filing on EDGAR →This is a quarterly earnings release for Q2 2026 (ended June 30, 2026) disclosing consolidated financial results including adjusted EPS of R$0.33 versus R$0.57 in 2Q25, adjusted EBITDA of R$3,503 million (down 3.2% YoY), and adjusted net income of R$1,150 million (down 41.2% YoY). The document contains a full income statement, balance sheet, cash flow statement, and detailed operational metrics typical of a quarterly results announcement. Material to investors as it shows significant earnings decline and operational challenges including revenue pressures, cost inflation, and higher funding costs.
View raw filing on EDGAR →Altimmune issued a press release on August 12, 2026 announcing financial results for Q2 2026 ended June 30, 2026, including consolidated balance sheets and statements of operations. The disclosure includes quarterly financial metrics (R&D expenses of $18.7M, G&A expenses of $7.6M, net loss of $22.8M), cash position of $519M, and material clinical milestones (PERFORMA Phase 3 initiation, RECLAIM Phase 2 positive data, RESTORE Phase 2 enrollment completion). This is a standard quarterly earnings release with financial statements and business updates furnished as Exhibit 99.1.
View raw filing on EDGAR →This is a news release announcing North American Construction Group's Q2 2026 financial results for the quarter ended June 30, 2026. The exhibit discloses quarterly revenue of $400.963 million (reported) and $456.082 million (combined), adjusted EBITDA of $93.5 million, net income of $9.4 million, and free cash flow of $23.0 million, along with a raised full-year 2026 combined revenue guidance to $1.6–$1.8 billion. The company also declared a quarterly dividend of $0.12 per share. This is a classic earnings release event material to investors.
View raw filing on EDGAR →Capstone Holding Corp. issued a press release on August 12, 2026, announcing Q2 2026 financial results with revenue of $21.5 million (up 67% YoY), gross profit of $6.0 million (up 92% YoY), and Stone Business Adjusted EBITDA of $2.0 million, along with reaffirmed full-year 2026 guidance and an investor presentation.
View raw filing on EDGAR →This is a standard earnings release disclosing quarterly and six-month financial results for Neonode Inc. for the periods ended June 30, 2026. Item 2.02 explicitly states the company "reported its earnings for the three and six months ended June 30, 2026" with the full press release attached as Exhibit 99.1, containing detailed financial statements, revenue analysis, and CEO commentary on operational performance. This is material to investors as it provides comprehensive financial performance data including revenue trends (20.4% decline in Q2), operating losses, cash position, and strategic updates on the company's licensing business transformation.
View raw filing on EDGAR →This is a clear earnings release disclosing Monopar's second quarter 2026 financial results, including net loss of $5.3 million (vs. $2.5 million in Q2 2025), R&D and G&A expenses, cash position of $134.3 million, and interest income. The press release is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes both financial metrics and material business updates regarding ALXN1840's NDA rolling submission and regulatory progress.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) filed on August 12, 2026. The press release discloses quarterly financial results including revenue ($23.7M, up 19%), net income ($0.3M or $0.01 per share vs. prior year loss), Adjusted EBITDA ($1.1M, up 128%), and raises full-year 2026 revenue guidance to 14-16% growth. The disclosure is material to investors as it reports actual financial performance and updates forward guidance.
View raw filing on EDGAR →Mannatech issued a press release on August 12, 2026 announcing financial and operating results for the second quarter ended June 30, 2026, disclosing net sales of $26.7 million, net income of $1.0 million ($0.53 per diluted share), and other key financial metrics. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02, which is the designated Item for results of operations and financial condition.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 disclosing financial results (net loss of $4.3 million, cash position of $17.1 million) and operational updates on the NEPHRO CRRT clinical trial (75% enrollment) and regulatory developments (KDIGO guideline inclusion). The filing explicitly states the press release is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings releases. Material to investors assessing the company's financial condition and clinical progress.
View raw filing on EDGAR →Sky Harbour Group Corporation issued a press release on August 12, 2026, announcing its financial results for the three and six months ended June 30, 2026, including consolidated revenues, operating cash flow, liquidity metrics, and adjusted EBITDA. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The filing includes specific financial highlights such as 50% revenue growth in Q2 2026 versus Q2 2025 and the company's first quarter of positive operating cash flow, making this material to investors' assessment of the registrant's financial performance.
View raw filing on EDGAR →Omeros Corporation issued a press release on August 12, 2026, announcing financial results for the three and six months ended June 30, 2026. The disclosure includes detailed quarterly financial metrics (net income of $13.2 million or $0.18 per share for Q2 2026), revenue figures for YARTEMLEA ($32.2 million gross, $28.5 million net), cash position ($132.0 million), and operating results. This is a standard earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →SeaStar Medical issued a press release on August 12, 2026, announcing financial results for the three and six months ended June 30, 2026, including net revenue of $0.6 million (82% increase vs. Q2 2025), net loss of $3.7 million, and cash position of $7.0 million. The disclosure is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The filing includes detailed financial tables and operational metrics that would materially affect a reasonable investor's assessment of the company's financial condition and performance.
View raw filing on EDGAR →Daily Journal Corporation announced financial results for the three and nine months ended June 30, 2026 via press release furnished as Exhibit 99.1. The disclosure includes consolidated revenue ($27.0M for Q3, $69.2M for nine months), operating income, net loss, and earnings per share, along with detailed segment performance and balance sheet data. This is a standard quarterly earnings release under Item 2.02, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Planet 13 announced Q2 2026 financial results via press release on August 12, 2026, disclosing revenue of $22.9 million, net loss of $5.6 million, and adjusted EBITDA loss of $0.5 million. The filing explicitly states "On August 12, 2026, Planet 13 Holdings Inc. (the "Company") announced via press release its results for the second quarter ended June 30, 2026" and furnishes the press release as Exhibit 99.1, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →BioCardia issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, including condensed consolidated statements of operations and selected balance sheet data. The disclosure includes quarterly net loss, operating expenses, cash position, and per-share metrics—all hallmarks of an earnings release. Item 2.02 explicitly covers "Results of Operations and Financial Condition," and the attached Exhibit 99.1 is the formal press release announcing Q2 2026 financial results.
View raw filing on EDGAR →Crown Crafts issued a press release on August 12, 2026 announcing financial results for the first quarter of fiscal 2027 ended June 28, 2026, with net sales of $16.8 million (up from $15.5 million) and net income of $2.1 million or $0.19 per share (versus a net loss of $1.1 million in the prior year).
View raw filing on EDGAR →Reviva disclosed Q2 2026 financial results (ended June 30, 2026) via press release, reporting a net loss of $2.4 million for the quarter and a cash position of $19.9 million as of quarter-end, along with recent clinical development milestones.
View raw filing on EDGAR →M-tron Industries disclosed its financial results for the three and six months ended June 30, 2026, reporting Q2 2026 revenue of $15.1 million (up 13.8%), net income of $1.9 million (up 19.9%), and adjusted EBITDA of $3.4 million (up 40.6%), along with a 37.2% increase in backlog to $84.0 million. The company also announced a conference call to discuss the results.
View raw filing on EDGAR →OptimizeRx issued a press release on August 12, 2026 announcing Q2 2026 financial results, including revenue of $20.5 million, net loss of $(0.7) million, and adjusted EBITDA of $4.9 million, along with reaffirmed full-year 2026 guidance.
View raw filing on EDGAR →This is a press release announcing Avino's Q2 2026 unaudited condensed interim consolidated financial results, with detailed financial highlights including revenues of $26.8 million (up 23% YoY), net income of $10.9 million (up 281% YoY), and diluted EPS of $0.06 (up 200% YoY). The document explicitly states "AVINO REPORTS Q2 2026 FINANCIAL RESULTS" and presents comprehensive operating and financial performance metrics for the quarter, making it a classic earnings release disclosure material to investors.
View raw filing on EDGAR →GEE Group Inc. issued a press release on August 12, 2026 announcing consolidated financial results for the fiscal 2026 third quarter and year-to-date periods ended June 30, 2026, reporting net income from continuing operations of $566 thousand for Q3 (versus a loss in the prior year), improved gross margins of 39.9% versus 35.4%, and adjusted EBITDA of $570 thousand.
View raw filing on EDGAR →The filing discloses Dyadic's second-quarter 2026 financial results via a press release dated August 12, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes consolidated statements of operations and balance sheets, reporting Q2 2026 revenue of $961,138, net loss of $2,123,884 ($(0.06) per share), and cash position of $4.8 million as of June 30, 2026. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →This is a press release announcing Almonty's second quarter 2026 financial results, including revenue of $43.0 million (498% YoY increase), net income of $181.8 million, and Adjusted EBITDA of $17.6 million. The document presents a comprehensive financial summary table, detailed commentary on operational performance, and cash flow metrics for the three and six months ended June 30, 2026. This is a classic earnings release disclosing quarterly financial results.
View raw filing on EDGAR →The 8-K discloses financial results for the fiscal quarter and six months ended June 30, 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release (Exhibit 99.1) provides detailed quarterly and six-month financial highlights, including revenue, gross profit, net loss, and Adjusted EBITDA metrics, along with management commentary and forward-looking guidance. This is a standard earnings release disclosure material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →The 8-K discloses CVD Equipment's second quarter 2026 financial results via a press release dated August 12, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes condensed consolidated statements of operations and balance sheets, reporting Q2 2026 net income of $12.6 million (driven by a $13.9 million gain on the SDC divestiture), net loss from continuing operations of $1.4 million, and key operational metrics. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →This exhibit is a press release announcing unaudited financial and operating results for the three months ended June 30, 2026 (Q1 FY2027). It discloses revenue of INR 1,879.0 million (down 10.4% YoY), Adjusted EBITDA of INR 215.9 million (up 4.7% YoY), and profit of INR 40.9 million (down 62.8% YoY), along with detailed segment performance and management commentary. This is a discrete earnings announcement, not a periodic financial report filing itself.
View raw filing on EDGAR →